12-hydroxyoctadecanoic acid

Modify Date: 2024-01-02 09:18:57

12-hydroxyoctadecanoic acid Structure
12-hydroxyoctadecanoic acid structure
Common Name 12-hydroxyoctadecanoic acid
CAS Number 106-14-9 Molecular Weight 300.477
Density 0.9±0.1 g/cm3 Boiling Point 436.3±18.0 °C at 760 mmHg
Molecular Formula C18H36O3 Melting Point 80-81ºC
MSDS Chinese USA Flash Point 231.8±17.7 °C

 Use of 12-hydroxyoctadecanoic acid


12-Hydroxystearic acid is a structurally simple and cost-effective low molecular weight organogelator, and its metal salts and derivatives find roles in many important applications[1][2].

 Names

Name 12-hydroxyoctadecanoic acid
Synonym More Synonyms

 12-hydroxyoctadecanoic acid Biological Activity

Description 12-Hydroxystearic acid is a structurally simple and cost-effective low molecular weight organogelator, and its metal salts and derivatives find roles in many important applications[1][2].
Related Catalog
In Vitro 12-Hydroxystearic acid (12HSA) and its derivatives have been studied in great detail due to it is effectiveness as a gelator and utility in lubricants[1].
References

[1]. Gordon R, et al. Aggregation of 12-Hydroxystearic Acid and Its Lithium Salt in Hexane: Molecular Dynamics Simulations. J Phys Chem B. 2016;120(29):7164-7173.

 Chemical & Physical Properties

Density 0.9±0.1 g/cm3
Boiling Point 436.3±18.0 °C at 760 mmHg
Melting Point 80-81ºC
Molecular Formula C18H36O3
Molecular Weight 300.477
Flash Point 231.8±17.7 °C
Exact Mass 300.266449
PSA 57.53000
LogP 6.03
Vapour Pressure 0.0±2.4 mmHg at 25°C
Index of Refraction 1.468
Storage condition −20°C

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
WI3850000
CHEMICAL NAME :
Stearic acid, 12-hydroxy-
CAS REGISTRY NUMBER :
106-14-9
BEILSTEIN REFERENCE NO. :
1726730
LAST UPDATED :
199701
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C18-H36-O3
MOLECULAR WEIGHT :
300.54
WISWESSER LINE NOTATION :
QV10YQ6

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
160 mg/kg/40W-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors Tumorigenic - tumors at site of application

MUTATION DATA

TYPE OF TEST :
Mutation in microorganisms
TEST SYSTEM :
Bacteria - Escherichia coli
DOSE/DURATION :
700 umol/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 122,87,1983 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - M1187 No. of Facilities: 5682 (estimated) No. of Industries: 85 No. of Occupations: 50 No. of Employees: 71848 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - M1187 No. of Facilities: 5607 (estimated) No. of Industries: 44 No. of Occupations: 38 No. of Employees: 52609 (estimated) No. of Female Employees: 4374 (estimated)

 Safety Information

Personal Protective Equipment dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes Xi: Irritant;
Risk Phrases R36/37/38
Safety Phrases S22-S24/25
RIDADR NONH for all modes of transport
WGK Germany 3
RTECS WI3850000
HS Code 2942000000

 Synthetic Route

 Customs

HS Code 2918199090
Summary 2918199090 other carboxylic acids with alcohol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0%

 Articles6

More Articles
Novel semisolid SNEDDS based on PEG-30-di-(polyhydroxystearate): Progesterone incorporation and in vitro digestion.

Int. J. Pharm. 486 , 77-87, (2015)

The aim of this work is to study the digestibility of PEG-30-di-(polyhydroxystearate) (Cithrol(®) DPHS) and its semisolid novel self-nanoemulsifying drug delivery systems (SNEDDS). Furthermore, the SN...

Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.

Int. J. Pharm. 495 , 972-80, (2015)

In this work, multifunctional lipid nanocapsules (M-LNC) were designed to combine the activity of the cytotoxic drug paclitaxel (PTX) with the immunostimulant CpG. This nanosystem, consisting of modif...

Core-shell structured gel-nanocarriers for sustained drug release and enhanced antitumor effect.

Int. J. Pharm. 484(1-2) , 163-71, (2015)

The present paper attempted to develop temperature-sensitive and core-shell structured gel-nanocarriers (gel-NCs) for paclitaxel (PTX) with 12-hydroxystearic acid (12-HSA) as an organic gelator, which...

 Synonyms

MFCD00004592
DL-12-hydroxystearic acid
Octadecanoic acid, 12-hydroxy-
EINECS 203-366-1
UNII:933ANU3H2S
12-Hydroxyoctadecanoic acid
DL-12-hydroxy stearic acid
12-Hydroxystearic acid
Top Suppliers:I want be here





Get all suppliers and price by the below link:

12-hydroxyoctadecanoic acid suppliers

12-hydroxyoctadecanoic acid price